Showing 621 - 640 results of 7,220 for search '"commercialization"', query time: 0.09s Refine Results
  1. 621

    Effect of JumpstartMD, a Commercial Low-Calorie Low-Carbohydrate Physician-Supervised Weight Loss Program, on 22,407 Adults by Sean Bourke, John Magaña Morton, Paul Williams

    Published 2020-01-01
    “…Background. Commercial weight loss programs provide valuable consumer options for those desiring support. …”
    Get full text
    Article
  2. 622

    Evaluating the Potential of Commercial Forest Inventory Data to Report on Forest Carbon Stock and Forest Carbon Stock Changes for REDD+ under the UNFCCC by Danae Maniatis, Yadvinder Malhi, Laurent Saint André, Danilo Mollicone, Nicolas Barbier, Sassan Saatchi, Matieu Henry, Laurent Tellier, Mathieu Schwartzenberg, Lee White

    Published 2011-01-01
    “…We provide an assessment of the use of commercial logging inventory data and ecological data to estimate a conservative EF (REDD+ phase 2) or to report on EF following IPCC Guidance and Guidelines (REDD+ phase 3). …”
    Get full text
    Article
  3. 623

    Determination of Volatile Compounds in Four Commercial Samples of Japanese Green Algae Using Solid Phase Microextraction Gas Chromatography Mass Spectrometry by Masayoshi Yamamoto, Susanne Baldermann, Keisuke Yoshikawa, Akira Fujita, Nobuyuki Mase, Naoharu Watanabe

    Published 2014-01-01
    “…Seaweed is consumed fresh or as seasoning in Japan. The commercial value is determined by quality, color, and flavor and is also strongly influenced by the production area. …”
    Get full text
    Article
  4. 624
  5. 625

    Air Transportation : a management perspective / by Wensveen, J. G.

    Published 2011
    Subjects:
    View in OPAC
    Book
  6. 626

    Communicating Through Letters and Reports / by Menning, J. H. (Jack Harwood), 1919-

    Published 1976
    Subjects: “…Commercial correspondence. 6362…”
    View in OPAC
    Book
  7. 627

    Business law / by MacIntyre, Ewan

    Published 2018
    Subjects: “…Commercial law England. 13357…”
    View in OPAC
    Book
  8. 628
  9. 629
  10. 630
  11. 631
  12. 632
  13. 633
  14. 634
  15. 635

    Assessment of Tools for Marker-Assisted Selection in a Marine Commercial Species: Significant Association between MSTN-1 Gene Polymorphism and Growth Traits by Irma Sánchez-Ramos, Ismael Cross, Jaroslav Mácha, Gonzalo Martínez-Rodríguez, Vladimir Krylov, Laureana Rebordinos

    Published 2012-01-01
    “…Specimens evaluated were from a commercial broodstock comprising 131 breeders (from which 36 males and 44 females contributed to the progeny). …”
    Get full text
    Article
  16. 636

    Effectiveness of a Commercial Lactic Acid Bacteria Intervention Applied to Inhibit Shiga Toxin-Producing Escherichia coli on Refrigerated Vacuum-Aged Beef by Katie R. Kirsch, Tamra N. Tolen, Jessica C. Hudson, Alejandro Castillo, Davey Griffin, T. Matthew Taylor

    Published 2017-01-01
    “…The objectives of this study were to assess the antimicrobial utility of a commercial LAB intervention against O157 and non-O157 Shiga-toxigenic E. coli (STEC) on intact beef strip loins during refrigerated vacuum aging and determine intervention efficacy as a function of mode of intervention application. …”
    Get full text
    Article
  17. 637

    Targeted CQA analytical control strategy for commercial antibody products: Replacing ion-exchange chromatography methods for charge heterogeneity with multi-attribute monitoring by Adam R. Evans, Joseph Mulholland, Michael J. Lewis, Ping Hu

    Published 2024-12-01
    “…Multi-attribute monitoring (MAM) methods have been used previously in commercial release and stability testing panels to ensure control of selected critical quality attributes (CQAs). …”
    Get full text
    Article
  18. 638
  19. 639

    Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States by Monica Kobayashi, Jamie Garside, Joehl Nguyen

    Published 2023-11-01
    “…**Objectives:** To describe HCRU and costs associated with first-line (1L) therapy for commercially insured patients with advanced or recurrent EC in the United States. …”
    Get full text
    Article
  20. 640